155 related articles for article (PubMed ID: 11266181)
1. Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor.
Darker JG; Porter RA; Eggleston DS; Smart D; Brough SJ; Sabido-David C; Jerman JC
Bioorg Med Chem Lett; 2001 Mar; 11(5):737-40. PubMed ID: 11266181
[TBL] [Abstract][Full Text] [Related]
2. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B.
Asahi S; Egashira S; Matsuda M; Iwaasa H; Kanatani A; Ohkubo M; Ihara M; Morishima H
Bioorg Med Chem Lett; 2003 Jan; 13(1):111-3. PubMed ID: 12467628
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands.
Lang M; Söll RM; Dürrenberger F; Dautzenberg FM; Beck-Sickinger AG
J Med Chem; 2004 Feb; 47(5):1153-60. PubMed ID: 14971895
[TBL] [Abstract][Full Text] [Related]
4. Structure, tissue distribution, and pharmacological characterization of Xenopus orexins.
Shibahara M; Sakurai T; Nambu T; Takenouchi T; Iwaasa H; Egashira SI; Ihara M; Goto K
Peptides; 1999; 20(10):1169-76. PubMed ID: 10573288
[TBL] [Abstract][Full Text] [Related]
5. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation.
Okumura T; Takeuchi S; Motomura W; Yamada H; Egashira Si S; Asahi S; Kanatani A; Ihara M; Kohgo Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):976-81. PubMed ID: 11162621
[TBL] [Abstract][Full Text] [Related]
6. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
[TBL] [Abstract][Full Text] [Related]
7. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
8. Structural properties of orexins for activation of their receptors.
Lang M; Bufe B; De Pol S; Reiser O; Meyerhof W; Beck-Sickinger AG
J Pept Sci; 2006 Apr; 12(4):258-66. PubMed ID: 16138386
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.
Smart D; Jerman JC; Brough SJ; Rushton SL; Murdock PR; Jewitt F; Elshourbagy NA; Ellis CE; Middlemiss DN; Brown F
Br J Pharmacol; 1999 Sep; 128(1):1-3. PubMed ID: 10498827
[TBL] [Abstract][Full Text] [Related]
10. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor.
Wieland HA; Söll RM; Doods HN; Stenkamp D; Hurnaus R; Lämmle B; Beck-Sickinger AG
Eur J Biochem; 2002 Feb; 269(4):1128-35. PubMed ID: 11856342
[TBL] [Abstract][Full Text] [Related]
11. Orexins and their receptors: structural aspects and role in peripheral tissues.
Voisin T; Rouet-Benzineb P; Reuter N; Laburthe M
Cell Mol Life Sci; 2003 Jan; 60(1):72-87. PubMed ID: 12613659
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of amylase release by Orexin is mediated by Orexin 2 receptor in AR42J cells.
Harris DM; Go VL; Reeve JR; Wu SV
Pancreas; 2002 Nov; 25(4):405-10. PubMed ID: 12409837
[TBL] [Abstract][Full Text] [Related]
13. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides.
Holmqvist T; Akerman KE; Kukkonen JP
Neurosci Lett; 2001 Jun; 305(3):177-80. PubMed ID: 11403934
[TBL] [Abstract][Full Text] [Related]
14. Orexins and the treatment of obesity.
Smart D; Haynes AC; Williams G; Arch JR
Eur J Pharmacol; 2002 Apr; 440(2-3):199-212. PubMed ID: 12007536
[TBL] [Abstract][Full Text] [Related]
15. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.
Sakurai T; Amemiya A; Ishii M; Matsuzaki I; Chemelli RM; Tanaka H; Williams SC; Richardson JA; Kozlowski GP; Wilson S; Arch JR; Buckingham RE; Haynes AC; Carr SA; Annan RS; McNulty DE; Liu WS; Terrett JA; Elshourbagy NA; Bergsma DJ; Yanagisawa M
Cell; 1998 Feb; 92(4):573-85. PubMed ID: 9491897
[TBL] [Abstract][Full Text] [Related]
16. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins.
Zhu Y; Miwa Y; Yamanaka A; Yada T; Shibahara M; Abe Y; Sakurai T; Goto K
J Pharmacol Sci; 2003 Jul; 92(3):259-66. PubMed ID: 12890892
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
[TBL] [Abstract][Full Text] [Related]
18. Orexins and orexin receptors: implication in feeding behavior.
Sakurai T
Regul Pept; 1999 Nov; 85(1):25-30. PubMed ID: 10588447
[TBL] [Abstract][Full Text] [Related]
19. Orexin receptors couple to Ca2+ channels different from store-operated Ca2+ channels.
Kukkonen JP; Akerman KE
Neuroreport; 2001 Jul; 12(9):2017-20. PubMed ID: 11435939
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
